The 3rd GPCR-Targeted Drug Discovery Summit is dedicated to unlocking the next wave of clinically relevant gpcr targets.
The 3rd GPCR-Targeted Drug Discovery Summit covers topics such as:
- The Latest Advancements in GPCR Structure-Based Drug Design to Improve Ligand-Receptor Affinity
- Optimize Screening & Modeling Tools to Enhance GPCR Pharmacology & Drug Design
- How Companies are Leveraging Human Genetics for Hit-to-Lead Optimization of More Effective GPCR Targeted Drugs
- The Expansion of GPCR-Targeting Modalities Beyond Traditional Small Molecules
- Methods to Delineate GPCR Signaling Pathway Cross-talk for Novel Druggable Paradigms
The 3rd GPCR-Targeted Drug Discovery Summit might be held in 2024.
